64Cu-ATSM Predicts Efficacy of Carbon Ion Radiotherapy Associated with Cellular Antioxidant Capacity
Authors:
- Ankita NachankarANAnkita Nachankar
- Takahiro OikeTOTakahiro Oike
- Hirofumi HanaokaHirofumi Hanaoka
- Ayaka KanaiAKAyaka Kanai
- Hiro SatoHSHiro Sato
- Yukari YoshidaYYYukari Yoshida
- Hideru ObinataHOHideru Obinata
- Makoto SakaiMakoto Sakai
- Naoto OsuNONaoto Osu
- Yuka HirotaYHYuka Hirota
- Akihisa TakahashiAkihisa Takahashi
- Atsushi ShibataASAtsushi Shibata
Open Access
Abstract
Carbon ion radiotherapy is an emerging cancer treatment modality that has a greater therapeutic window than conventional photon radiotherapy. To maximize the efficacy of this extremely scarce medical resource, it is important to identify predictive biomarkers of higher carbon ion relative biological effectiveness (RBE) over photons. We addressed this issue by focusing on cellular antioxidant capacity and investigated 64Cu(II)-diacetyl-bis(N4-methylthiosemicarbazone) (64Cu-ATSM), a potential radioligand that reflects an over-reduced intracellular environment. We found that the carbon ion RBE correlated with 64Cu-ATSM uptake both in vitro and in vivo. High RBE/64Cu-ATSM cells showed greater steady-state levels of antioxidant proteins and increased capacity to scavenge reactive oxygen species in response to X-rays than low RBE/64Cu-ATSM counterparts; this upregulation of antioxidant systems was associated with downregulation of TCA cycle intermediates. Furthermore, inhibition of nuclear factor erythroid 2-related factor 2 (Nrf2) sensitized high RBE/64Cu-ATSM cells to X-rays, thereby reducing RBE values to levels comparable to those in low RBE/64Cu-ATSM cells. These data suggest that the cellular activity of Nrf2-driven antioxidant systems is a possible determinant of carbon ion RBE predictable by 64Cu-ATSM uptake. These new findings highlight the potential clinical utility of 64Cu-ATSM imaging to identify high RBE tumors that will benefit from carbon ion radiotherapy.Keywords
Funding Information
- Ministry of Education, Culture, Sports, Science, and Technology of Japan (JPMXS0420600120)
This publication has 48 references indexed in Scilit:
- Impact of carbon ion radiotherapy for unresectable osteosarcoma of the trunkCancer, 2012
- Some thoughts on the mechanism of cellular trapping of Cu(II)-ATSMNuclear Medicine and Biology, 2010
- Radio-copper-labeled Cu-ATSM: an indicator of quiescent but clonogenic cells under mild hypoxia in a Lewis lung carcinoma modelNuclear Medicine and Biology, 2009
- Contributions of Direct and Indirect Actions in Cell Killing by High-LET RadiationsRadiation Research, 2009
- An Imaging Comparison of 64Cu-ATSM and 60Cu-ATSM in Cancer of the Uterine CervixJournal of Nuclear Medicine, 2008
- Upregulation of thioredoxin system via Nrf2-antioxidant responsive element pathway in adaptive-retinal neuroprotection in vivo and in vitroFree Radical Biology and Medicine, 2007
- Clonogenic assay of cells in vitroNature Protocols, 2006
- Cell line-dependent differences in uptake and retention of the hypoxia-selective nuclear imaging agent Cu-ATSMNuclear Medicine and Biology, 2005
- Comparative studies of Cu-64-ATSM and C-11-Acetate in an acute myocardial infarction model: ex vivo imaging of hypoxia in ratsNuclear Medicine and Biology, 1999
- Differential expressions of cyclin A and the retinoblastoma gene product in histological subtypes of lung cancer cell linesJournal of Cancer Research and Clinical Oncology, 1997